NextRNA Therapeutics
PrivateLast Round
Series A
Mar 1, 2022
Total Funding Raised
$56.1M
Company Overview
NextRNA Therapeutics is a biotechnology company that developed small molecule therapeutics targeting dysregulated long non-coding RNAs (lncRNAs) to treat diseases in oncology and neuroscience.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NextRNA Therapeutics Comparables
Compare NextRNA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arrakis Therapeutics | 88% | |
| Amaroq Therapeutics | 86% | |
| Expansion Therapeutics | 84% |
NextRNA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 1, 2022 | ||||
| Seed | Mar 1, 2022 |
Key People
Founding team and executive leadership
NextRNA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | Seed, Series A |
| Circle Squared Alternative Investments | Series A |
| Evans Capital | Seed, Series A |
| Rivas Capital | Seed, Series A |
| Willett Advisors | Seed, Series A |
| Cobro Ventures | Seed, Series A |
| LightChain Capital | Seed, Series A |
NextRNA Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NextRNA Therapeutics's valuation, stock price, and market status.
Is NextRNA a public or private company?
NextRNA is a private company.
What is the current stock price of NextRNA?
NextRNA is a private company with no public stock price. No recent secondary market data is available.
How much is NextRNA worth (valuation)?
Valuation information for NextRNA is not publicly available.
Can I buy NextRNA stock?
NextRNA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NextRNA's last funding round?
NextRNA's most recent funding round was Series A on March 1, 2022.
Who are the main investors in NextRNA?
Key investors in NextRNA include Cobro Ventures, LightChain Capital.
Will NextRNA IPO soon?
No public IPO plans have been announced for NextRNA.
How can I track NextRNA secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NextRNA's secondary market activity and sign up for updates.